Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
DRDATSONS
DRDATSONS
6.40+0.0 (+0.00%)
1 Jun, 12:00 AM

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap
-
P/E (TTM)
-
P/B
-
P/S (TTM)
-
EV/EBITDA
-
CAPE (5Y)
-
ROE (TTM)
-
ROCE (TTM)
-
ROA (TTM)
-
Avg 3Y ROE
-
Earnings 3Y CAGR
-
Sales 3Y CAGR
-
Sales 5Y CAGR
-
Debt/Equity
-
Consensus TP
-
Strong Buy %
-
Promoter Holding
-
Pledged %
-

Share Price

Track Dr Datsons Labs Ltd's current share price, historical price chart, 52-week high/low, and performance across different time periods.

Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Stock Analysis

Fundamental analysis overview of Dr Datsons Labs Ltd covering key investment insights, growth drivers, risk factors, and potential red flags.

Views
Red Flags
Positive
Not enough talking points with positive stance
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of nan% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Neutral
Not enough talking points with neutral stance
No red flags found!
No significant red flags found in the stock.

Financial Snapshot

See detailed analysis

Multi-year trends for Dr Datsons Labs Ltd covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY
Not enough data
Profit After Tax FY
Not enough data
ROE FY
Not enough data
EBITDA FY
Not enough data

Dr Datsons Labs Ltd Shareholding Pattern

Quarterly breakdown of Dr Datsons Labs Ltd ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

May 2011Jun 2011Sep 2011Dec 2011Mar 2012Jun 2012Sep 2012Dec 2012Mar 2013Jun 2013Sep 2013Dec 2013Mar 2014Jun 2014Sep 2014Dec 2014Mar 2015
Total Promoter
60.24
60.24
60.24
60.43
57.51
52.38
47.58
46.79
41.22
25.35
25.08
24.79
10.01
4.91
4.53
-
-
Indian Promoter
60.24
60.24
60.24
60.43
57.51
52.38
47.58
46.79
41.22
25.35
25.08
24.79
10.01
4.91
4.53
-
-
Foreign Promoter
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
2.77
4.81
4.57
4.46
0.02
0.20
0.27
1.06
0.49
1.68
1.51
1.51
56.79
34.57
1.35
38.87
2.67
Mutual Funds / UTI
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FI/Bank/Insurance
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.56
0.00
0.00
0.00
0.00
0.00
0.98
1.35
1.68
0.47
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
2.77
4.81
4.57
4.46
0.02
0.20
0.27
0.50
0.48
1.68
1.51
1.51
56.79
33.60
0.00
37.19
2.20
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Non-Institution
36.99
34.95
35.19
35.12
42.47
47.41
52.15
52.15
58.29
72.97
73.41
73.69
33.20
60.52
94.12
61.13
97.33
Bodies Corporate
13.38
20.89
27.65
29.91
35.84
41.54
46.40
47.85
52.04
53.95
53.95
54.98
28.99
20.18
25.24
13.87
15.24
Others (incl. Retail)
No. of shareholders
23.61
4,369
14.06
1,459
7.54
939
5.21
821
6.63
805
5.87
1,420
5.75
859
4.30
964
6.25
1,738
19.02
3,610
19.46
3,743
18.71
3,220
4.21
3,353
40.34
14,515
68.88
20,391
47.26
24,183
82.09
31,632

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Dr Datsons Labs Ltd shares as reported to NSE and BSE.

No bulk, block or insider trade data available.

No corporate action data available.

Company Profile

Overview of Dr Datsons Labs Ltd covering business description, industry classification, key management, financial ratios, and listed exchange details.

Dr. Datsons Labs Ltd is a Indian based company. The Company engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutio...
Key personnel
Sameer Talim
Chief Executive Officer
Dr. Bhanu Pandey
President - Business Development
Mr. Lalit Shukla
President - Finance
Col ( Retd ) Ashish Kumar Basu
Head - Admin & HR
Dr. Praful Mathur, Ph.D
Head - R & D APIs
Mr. Suhas Pise
Head - Global Pharma Manufacturing & Supply Chain
Mr. Pradeep Sarode
Head Manufacturing - Formulations
Mr. Anil Kumar Singh
Head QA - Formulations
View all
Incorporated on
03 Jan 2006
Last Annual
31 Mar 2014
Last Interim
31 Mar 2012
No. of Employees
-
IPO date
-
Free Float
-
Website
Phone no.
+
Address
NO 34 AANJANEYA HOUSE POSTAL COLONY CHEMBUR, , 400071, India

Frequently Asked Questions

What is the current share price of Dr Datsons Labs Ltd?
The current share price of Dr Datsons Labs Ltd is ₹ 6.40 as of 1 Jun 2017.
What is the market capitalisation of Dr Datsons Labs Ltd?
The market capitalisation of Dr Datsons Labs Ltd stands at -.
What is the PE ratio of Dr Datsons Labs Ltd?
The Price-to-Earnings (PE) ratio of Dr Datsons Labs Ltd is - as of the latest trailing twelve months data.
What is the ROE and ROCE of Dr Datsons Labs Ltd?
Dr Datsons Labs Ltd has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of - as per the latest financial reports.
What is the 52-week high and low of Dr Datsons Labs Ltd?
The 52-week high of Dr Datsons Labs Ltd is - and the 52-week low is -.
What is the dividend yield of Dr Datsons Labs Ltd?
The dividend yield of Dr Datsons Labs Ltd is - based on the current market price.
What is the FII and DII holding in Dr Datsons Labs Ltd?
Foreign Institutional Investors (FII) hold -, Domestic Institutional Investors (DII) hold - of Dr Datsons Labs Ltd shares.
What sector does Dr Datsons Labs Ltd belong to?
Dr Datsons Labs Ltd operates in the Healthcare sector.
What is the beta of Dr Datsons Labs Ltd?
The beta of Dr Datsons Labs Ltd is 0.51, indicating its price volatility relative to the broader market.
What is the RSI of Dr Datsons Labs Ltd?
The 14-day Relative Strength Index (RSI) of Dr Datsons Labs Ltd is 28.85, placing it in the oversold zone. An RSI above 70 is considered overbought and below 30 is considered oversold.